Monday 19 October 2026
Export THMO’s income statement to Excel — free account
ThermoGenesis Holdings, Inc.
THMO Healthcare Medical Devices
ThermoGenesis Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $9.4 million, down 9.90% from fiscal 2022. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow THMO
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Jun '17 | Dec '16 | Jun '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 3 | 2 | 5 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.14 | 0.19 | 1.28 | 1.35 | 0.95 | 0.51 | 2.23 | 2.16 | 2.34 | 0.61 |
Altman Z-Score |
(37.75) | (19.71) | (17.73) | (16.89) | (21.23) | (30.41) | (4.93) | (4.66) | 7.57 | (4.44) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(91.73) | (46.90) | (41.19) | (39.16) | (51.57) | (68.86) | (11.67) | (11.27) | (10.25) | (8.79) |
P/Operating CF |
(0.65) | (1.66) | (36.54) | (5.17) | 48.20 | 10.97 | (21.26) | (14.93) | (57.97) | (0.95) |
Beneish M-Score |
(9.50) | (1.65) | (4.53) | (1.66) | (4.98) | (14.26) | — | — | — | (3.63) |
P/B ratio |
0.00 | 0.59 | 3.51 | 2.23 | 13.57 | 0.73 | 0.93 | 1.02 | 0.97 | 0.25 |
Price to Tangible BV |
0.00 | 1.57 | 9.18 | 3.51 | 0.00 | 1.13 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.91 | 0.67 | 1.49 | 1.29 | 1.01 | 0.38 | 2.46 | 2.15 | 2.17 | 0.35 |
EV/EBITDA |
10.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 652.14 |
EV/Operating CF |
(2.30) | (0.97) | (2.10) | (0.87) | (4.05) | (0.53) | (5.11) | (4.33) | (2.13) | (0.21) |
EV/FCF |
(1.57) | (0.92) | (2.07) | (0.87) | (3.84) | (0.45) | (4.85) | (4.12) | (1.96) | (0.19) |
Quick Ratio |
0.25 | 0.53 | 1.26 | 1.39 | 0.81 | 0.61 | 1.11 | 1.62 | 1.62 | 1.62 |
Current Ratio |
0.44 | 0.95 | 2.36 | 2.49 | 1.42 | 1.36 | 2.10 | 2.47 | 2.32 | 2.32 |
Net Debt/EBITDA |
(2.38) | 2.35 | (0.66) | 0.21 | (0.49) | 0.03 | (0.37) | (0.08) | 0.35 | 1.21 |
Debt/Assets |
0.00% | 0.00% | 44.77% | 31.77% | 32.41% | 8.04% | 13.11% | 7.46% | 4.99% | 4.99% |
Debt/Equity |
0.00 | 0.00 | 2.72 | 1.13 | 5.38 | 0.17 | 0.20 | 0.11 | 0.08 | 0.08 |
Asset Turnover |
0.62 | 0.52 | 0.45 | 0.54 | 0.87 | 0.29 | 0.25 | 0.30 | 0.24 | 0.24 |
Operating CF/Net income |
0.21 | 0.65 | 0.58 | 0.88 | 0.34 | 0.18 | 0.73 | 0.25 | 0.52 | 0.52 |
Capex/Depreciation |
(0.18) | (0.09) | (0.02) | 0.00 | (0.06) | (0.67) | 0.00 | (0.03) | 0.00 | (0.09) |
Interest Coverage |
(0.86) | (1.10) | (1.18) | (1.12) | (1.06) | (16.15) | — | (0.46) | — | (5.83) |
| 13,773.95% | (335.42%) | (245.58%) | (481.90%) | (248.38%) | (198.86%) | (14.26%) | (92.20%) | (57.60%) | (55.34%) | |
| (117.41%) | (56.30%) | (54.82%) | (90.65%) | (63.68%) | (120.86%) | (9.31%) | (60.09%) | (37.25%) | (36.93%) | |
ROIC |
0.00% | 0.00% | (84.29%) | (104.19%) | (175.04%) | (494.38%) | 0.00% | (19.07%) | 0.00% | (23.48%) |
Return on Tangible Assets |
449.82% | (1,791.73%) | (115.21%) | (154.56%) | (195.25%) | (823.47%) | (50.81%) | (323.71%) | (181.12%) | (181.12%) |
Average Days of Receivables |
36.67 | 64.94 | 28.79 | 51.77 | 35.75 | 56.95 | 77.36 | 93.00 | 96.96 | 96.96 |
Research and Development Expense of Revenue |
13.59% | 15.83% | 23.77% | 25.42% | 18.36% | 31.14% | 37.35% | 17.19% | 27.08% | 27.08% |
Selling, General and Administrative Expense of Revenue |
76.45% | 69.10% | 91.62% | 78.79% | 61.57% | 99.72% | 74.95% | 85.38% | 87.01% | 87.01% |
Intangible Assets out of Total Assets |
0.00 | 0.11 | 0.10 | 0.10 | 0.15 | 0.16 | 0.70 | 0.71 | 0.68 | 0.68 |
Share Based Compensation of Revenue |
0.41% | 2.55% | 27.54% | 9.03% | 4.71% | 6.74% | 0.00% | 10.06% | 0.00% | 6.22% |
Graham Net Nets |
(7.27) | (2.63) | (0.19) | 0.02 | (0.38) | 0.15 | (0.21) | (0.16) | (0.10) | (0.60) |
Graham Number |
17.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1,562.50%) | (583.32%) | (95.14%) | (131.23%) | (78.35%) | (851.32%) | (29.59%) | (138.51%) | (256.62%) | (286.98%) |
Free Cash Flow Yield |
(411.29%) | (390.58%) | (56.35%) | (109.96%) | (27.68%) | (167.35%) | (22.76%) | (24.19%) | (47.36%) | (302.19%) |
Revenue per Share |
3.99 | 19.03 | 35.46 | 69.90 | 207.75 | 236.48 | 534.49 | 733.59 | 48.57 | 2,168.91 |
Operating CF per Share |
(1.57) | (13.22) | (25.26) | (103.25) | (51.91) | (170.73) | (147.42) | (364.39) | (39.19) | (1,750.00) |
Capex per Share |
(0.73) | (0.73) | (0.35) | (0.16) | (2.90) | (30.27) | 0.00 | (18.94) | 0.00 | (129.09) |
Free Cash Flow per Share |
(2.30) | (13.94) | (25.61) | (103.41) | (54.81) | (201.00) | (147.42) | (383.33) | (39.19) | (1,879.09) |
Cash per Share |
0.84 | 7.58 | 27.78 | 51.37 | 66.19 | 58.68 | 156.13 | 182.98 | 23.76 | 1,060.91 |
Shareholders Equity per Share |
(1.51) | 6.03 | 12.96 | 42.11 | 14.59 | 164.57 | 1,476.09 | 1,557.42 | 131.40 | 5,867.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1.51) | 6.03 | 12.96 | 42.11 | 14.59 | 164.57 | 1,476.09 | 1,557.42 | 131.40 | 5,867.82 |
Free Cash Flow |
(5.45) | (7.68) | (6.71) | (14.42) | (3.44) | (8.22) | (3.32) | (7.59) | (9.62) | (10.33) |
Working Capital |
(6.58) | (0.62) | 8.62 | 9.16 | 2.84 | 2.26 | 5.99 | 6.66 | 7.30 | 7.30 |
Capital Expenditures |
(1.73) | (0.40) | (0.09) | (0.02) | (0.18) | (1.24) | (0.30) | (0.37) | (0.71) | (0.71) |
Net Current Asset Value |
(9.64) | (5.18) | (2.29) | 0.31 | (4.78) | 0.75 | (6.44) | (4.92) | (4.78) | (4.78) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.18 | 0.04 | 0.01 | 0.00 | 0.01 | 0.13 | 0.00 | 0.03 | 0.00 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.46 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
3.66 | 3.52 | 3.38 | 4.42 | 1.56 | 0.72 | 0.11 | 4.65 | 0.39 | 2.73 |
Cash ROIC |
344.32% | (102.44%) | (33.70%) | (73.33%) | (34.41%) | (79.78%) | (7.64%) | (19.99%) | (23.71%) | (25.46%) |
Accounts Receivable Turnover |
6.71 | 8.07 | 8.79 | 7.33 | 9.36 | 4.77 | 3.85 | 4.23 | 3.76 | 2.87 |
Accounts Payable Turnover |
8.50 | 7.40 | 4.38 | 6.03 | 3.80 | 3.32 | 4.19 | 4.09 | 3.47 | 2.38 |
Inventory Turnover |
3.17 | 1.79 | 1.03 | 1.81 | 1.84 | 1.61 | 1.83 | 2.41 | 2.56 | 2.24 |
Average Days of Payables |
46.05 | 38.51 | 80.54 | 58.76 | 71.85 | 118.25 | 98.35 | 67.28 | 105.23 | 105.23 |
Days of Inventory on Hand |
68.30 | 156.56 | 338.07 | 252.81 | 172.99 | 219.27 | 226.97 | 151.99 | 142.78 | 142.78 |
Average Receivables |
1.41 | 1.30 | 1.06 | 1.33 | 1.39 | 2.03 | 3.13 | 3.44 | 3.17 | 4.15 |
Average Payables |
0.88 | 1.05 | 1.32 | 1.41 | 1.94 | 2.25 | 1.84 | 2.12 | 2.65 | 3.86 |
Average Inventory |
2.37 | 4.35 | 5.63 | 4.68 | 3.99 | 4.65 | 4.21 | 3.61 | 3.59 | 4.10 |
Average Assets |
15.31 | 20.02 | 20.76 | 18.04 | 14.91 | 32.86 | 49.02 | 48.42 | 49.90 | 50.33 |
Average Common Equity |
(0.13) | 3.36 | 4.63 | 3.39 | 3.82 | 19.97 | 32.02 | 31.56 | 32.27 | 33.59 |
Columns are period end dates